Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.
Company Details
- Employees
- 64
- Founded
- -
- Address
- 2220 Welsch Industrial Ct, St. Louis,mo 63146,united States
- Phone
- 314-887-7777
- ge****@****ail.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- geneoscopy.com
- Keywords
- Life Sciences, Noninvasive Diagnostic Screening, Colorectal Cancer Screening, GI Health, GI Disease Companion Diagnostics, seRNA, RNA Biomarkers, Precision Medicine Partnerships, IBD.
- HQ
- St. Louis, MO
Geneoscopy Questions
Geneoscopy's helpline number is 314-887-7777
Geneoscopy's website is geneoscopy.com
Geneoscopy's LinkedIn profile is https://www.linkedin.com/company/geneoscopy
Geneoscopy has
64 employees.
View email and phone details for 64
employees at Geneoscopy.
Geneoscopy's industry is
Biotechnology Research
Geneoscopy's top competitors are
Foundation Medicine,
Natera,
Neogenomics Laboratories,
Genedx,
Guardant Health,
Exact Sciences,
Biostl,
Freenome,
Tempus Ai,
Wugen.
Geneoscopy's support email address is geneoscopy@gmail.com
Geneoscopy's categories are Biotechnology Research
Geneoscopy's founding year is 2015
